Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade.

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials ...

Market Implications: This study update could positively influence AstraZeneca’s stock performance by demonstrating the effectiveness of BGF in managing COPD, potentially boosting investor confidence.

In this video, Cedric "Jamie" Rutland, MD, discusses available treatment options in COPD, what's in the pipeline and research on new COPD treatments.

“Identifying new cell types, in particular new progenitor cells, that are injured in COPD could really accelerate the development of new treatments.” The research was published in the journal ...

An experimental treatment which sees a patient’s own cells transplanted into damaged parts of their lung could offer a new hope for sufferers of chronic obstructive pulmonary disease (COPD ...

New research has found that a process initiated in white blood cells known as neutrophils may lead to worse outcomes for some patients with chronic obstructive pulmonary disease (COPD). The ...

"Potential new treatment combats COPD and other lung diseases." ScienceDaily. ScienceDaily, 13 February 2017. <www.sciencedaily.com / releases / 2017 / 02 / 170213151303.htm>.

Review Article Published: 01 June 2002 New treatments for copd Peter J. Barnes Nature Reviews Drug Discovery 1, 437–446 (2002) Cite this article ...